Biocon Limited FII & DII Activity
5-Day Flow Trend
| Date | FII Net (₹ Cr) | DII Net (₹ Cr) |
|---|---|---|
| 2026-04-21 | -1,059.93 | +2,966.89 |
| 2026-04-20 | +683.2 | -4,721.48 |
| 2026-04-18 | +683.2 | -4,721.48 |
Today's Institutional Flow
Foreign Institutional Investors (FII) sold ₹1059.93 Cr in Biocon Limited shares on a cash basis, reflecting net outflows. Domestic Institutional Investors (DII) countered with strong buying of ₹2966.89 Cr, signaling robust local support. FII absence in F&O suggests no leveraged bearish or bullish positioning today.
Trend vs 5-Day Average
Today’s FII selling marks a reversal from their 5-day average inflow of ₹683.2 Cr, indicating a shift in foreign sentiment. DIIs, despite today’s heavy buying, continue to underperform their 5-day average of ₹-4721.48 Cr, suggesting underlying net selling pressure persists.
F&O Positioning Signal
With no FII F&O activity recorded, directional leverage remains muted. However, the FII Index Futures Long/Short ratio at 1.2 implies a broadly constructive macro hedge, contrasting with their Biocon cash market exit.
Implication for Finance
Net institutional inflows today may stabilize midcap pharma stocks, with DIIs likely driving near-term price action for Biocon Limited.
Market-wide FII/DII data — same for all F&O stocks. Date: 2026-04-21